JPH07503256A - フェニルイミダゾリジノン誘導体およびその製造法 - Google Patents
フェニルイミダゾリジノン誘導体およびその製造法Info
- Publication number
- JPH07503256A JPH07503256A JP6511639A JP51163994A JPH07503256A JP H07503256 A JPH07503256 A JP H07503256A JP 6511639 A JP6511639 A JP 6511639A JP 51163994 A JP51163994 A JP 51163994A JP H07503256 A JPH07503256 A JP H07503256A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- formula
- imidazol
- imidazolidin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (9)
- 1.式(I) ▲数式、化学式、表等があります▼(I){式中、nは1、2または3であり、 同一若しくは異なっていてよいR、R1およびR2はそれぞれ、水素、ハロゲン 、ヒドロキシ、シアノ、C1−C6アルキル、CF3,C1−C6アルコキシ、 C1−C6アルキルチオ、ホルミル、C2−C6アルカノイル、カルボキシ、C 1−C6アルコキシカルボニル、ニトロ、−N(R4R5)(式中、R4および R5は互いに独立して、水素、C1−C6アルキル、ホルミル若しくはC2−C 6アルカノイルである)、または(R6R7)N−SO2基(式中、R6および R7は互いに独立して水素若しくはC1−C6アルキルである)であり、 R3は式 a)▲数式、化学式、表等があります▼またはb)▲数式、化学式、表等があり ます▼(式中、同一若しくは異なっていてよいR8およびR10は、それぞれ水 素若しくはC1−C6アルキルであり、R9は水素、C1−C6アルキル若しく は窒素保護基である)のイミダゾリル基である} を有する化合物および医薬上許容可能なその塩。
- 2.式(I){式中,同一または異なっていてよいR、R1およびR2はそれぞ れ、水素、ハロゲン、シアノ、CF3、C1−C4アルキルチオ、C1−C4ア ルコキシまたは−N(R4R5)(式中、R4およびR5は互いに独立して、水 素、C1−C4アルキル、ホルミル若しくはC2−C4アルカノイルである)で あり、nは1または2であり、R3は上記の定義と同様であり、R8、R9およ びR10は互いに独立して、水素またはC1−C4アルキルである}を有する請 求項1に記載の化合物および医薬上許容可能なその塩。
- 3.1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3−ク ロロフェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−フェニルイミ ダゾリジン−2−オン;1−(5−メチル−1H−イミダゾール−4−イル)メ チル−3−(3−ブロモフェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3−シアノ フェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3−メチル チオフェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3−メチル フェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3,5−ジ メチルフェニル)−イミダゾリジン−2−オン; 1−(5−メチル−1H−イミダゾール−4−イル)メチル−3−(3,5−ジ クロロフェニル)−イミダゾリジン−2−オン; 1−(1H−イミダゾール−4−イル)メチル−3−(3−クロロフェニル)− イミダゾリジン−2−オン;1−(1H−イミダゾール−4−イル)メチル−3 −フェニルイミダゾリジン−2−オン; 1−(1H−イミダゾール−4−イル)メチル−3−(3−ブロモフェニル)− イミダゾリジン−2−オン;1−(1H−イミダゾール−4−イル)メチル−3 −(3−シアノフェニル)−イミダゾリジン−2−オン;1−(1H−イミダゾ ール−4−イル)メチル−3−(3−メチルチオフェニル)−イミダゾリジン− 2−オンからなる群から選択された化合物および医薬上許容可能なその塩。
- 4.前記塩が塩酸塩である、請求項1から3のいずれか一項に記載の化合物の塩 。
- 5.a)式(II) ▲数式、化学式、表等があります▼(II)(式中、R、R1およびR3は上記 の定義と同様である)の化合物またはその塩を、式(III)R3−(CH2) n−Y(III) (式中、nは請求項1における定義と同様であり、Yは離脱基であり、請求項1 における定義と同様であるR3において、R9はC1−C6アルキル基若しくは 窒素保護基である)の化合物と反応させて、式(I)(式中、R9は水素を除く 以外は請求項1における定義と同様である)の化合物を得るか、または b)式(IV) ▲数式、化学式、表等があります▼(IV){式中、 R、R1、R2およびnは請求項1における定義と同様であり、R11は式 c)▲数式、化学式、表等があります▼まはたd)▲数式、化学式、表等があり ます▼(式中、R8およびR10は請求項1における定義と同様であり、R12 は窒素保護基である)} の化合物を脱保護して、式(I)(式中、R9は水素である)の化合物を得るか 、 所望の場合には、式(I)の化合物を別の式(I)の化合物に転換するか、およ び/または、所望の場合には、式(I)の化合物を医薬上許容可能なその塩に転 換するか、および/または、所望の場合には、塩を遊離化合物に転換するか、お よび/または、所望の場合には、式(I)の化合物の異性体混合物を単一の異性 体に分離することを含む、請求項1の式(I)の化合物またはその塩の製造法。
- 6.好適な担体および/または溶離剤、並びに、活性素として、請求項1に定義 されている式(I)の化合物または医薬上許容可能なその塩を含む医薬組成物。
- 7.5HT3受容体アンタゴニストとして使用するための請求項1に記載の化合 物または塩。
- 8.中枢神経系の障害の治療に使用するための請求項1に記載の化合物または塩 。
- 9.抗不安、抗嘔吐若しくは認識活性剤、または薬剤中毒防止剤として、並びに 腸運動障害および偏頭痛の治療に使用するための請求項1に記載の化合物または 塩。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929224144A GB9224144D0 (en) | 1992-11-18 | 1992-11-18 | Phenyl-imidazolidinone derivatives and process for their preparation |
GB9224144.7 | 1992-11-18 | ||
PCT/EP1993/002924 WO1994011347A1 (en) | 1992-11-18 | 1993-10-22 | Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07503256A true JPH07503256A (ja) | 1995-04-06 |
JP3794696B2 JP3794696B2 (ja) | 2006-07-05 |
Family
ID=10725269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51163994A Expired - Fee Related JP3794696B2 (ja) | 1992-11-18 | 1993-10-22 | フェニルイミダゾリジノン誘導体およびその製造法 |
Country Status (19)
Country | Link |
---|---|
US (1) | US5424328A (ja) |
EP (1) | EP0623114B1 (ja) |
JP (1) | JP3794696B2 (ja) |
CN (1) | CN1093702A (ja) |
AT (1) | ATE179701T1 (ja) |
AU (1) | AU666793B2 (ja) |
CA (1) | CA2127536C (ja) |
DE (1) | DE69324794T2 (ja) |
ES (1) | ES2133415T3 (ja) |
FI (1) | FI943376A0 (ja) |
GB (1) | GB9224144D0 (ja) |
HU (1) | HUT70395A (ja) |
IL (1) | IL107371A (ja) |
NZ (1) | NZ257117A (ja) |
PL (1) | PL174416B1 (ja) |
RU (1) | RU2126403C1 (ja) |
TW (1) | TW233297B (ja) |
WO (1) | WO1994011347A1 (ja) |
ZA (1) | ZA938206B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780492A (en) * | 1996-04-03 | 1998-07-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6455424B1 (en) * | 2000-08-07 | 2002-09-24 | Micron Technology, Inc. | Selective cap layers over recessed polysilicon plugs |
EP2858501A4 (en) * | 2012-05-22 | 2015-12-09 | Merck Sharp & Dohme | TRK-A KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459757A (en) * | 1965-10-22 | 1969-08-05 | American Cyanamid Co | Imidazolidines |
US3491098A (en) * | 1967-05-29 | 1970-01-20 | Sterling Drug Inc | 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines |
US3702327A (en) * | 1970-12-28 | 1972-11-07 | Aldrich Chem Co Inc | N-beta-1-(3-phenylimidazolidin-2-one)ethyl 4,4-ethylene dioxypiperidines |
JPS6133172A (ja) * | 1984-07-24 | 1986-02-17 | Kotobuki Seiyaku Kk | 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法 |
US4600430A (en) * | 1985-02-22 | 1986-07-15 | Eli Lilly And Company | Pyridinylimidazolidinone compounds |
FI90869C (fi) * | 1986-11-14 | 1994-04-11 | Tanabe Seiyaku Co | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi |
AU611976B2 (en) * | 1987-12-24 | 1991-06-27 | John Wyeth & Brother Limited | Aroyl urea and carbamic acid derivatives of azabicyclo compounds |
IT1230703B (it) * | 1989-01-26 | 1991-10-29 | Luso Farmaco Inst | Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono. |
GB2248058B (en) * | 1990-09-21 | 1994-09-14 | Orion Yhtymae Oy | Aromatase inhibiting 4(5)-imidazoles |
GB9106571D0 (en) * | 1991-03-27 | 1991-05-15 | Erba Carlo Spa | Derivatives of substituted imidazol-2-one and process for their preparation |
GB9020889D0 (en) * | 1990-09-25 | 1990-11-07 | May & Baker Ltd | New compositions of matter |
IT1255802B (it) * | 1992-08-07 | 1995-11-16 | Luso Farmaco Inst | Derivati imidazolici ad attivita' a ii antagonista |
-
1992
- 1992-11-18 GB GB929224144A patent/GB9224144D0/en active Pending
-
1993
- 1993-10-22 JP JP51163994A patent/JP3794696B2/ja not_active Expired - Fee Related
- 1993-10-22 DE DE69324794T patent/DE69324794T2/de not_active Expired - Fee Related
- 1993-10-22 EP EP93923529A patent/EP0623114B1/en not_active Expired - Lifetime
- 1993-10-22 AU AU53364/94A patent/AU666793B2/en not_active Ceased
- 1993-10-22 HU HU9401948A patent/HUT70395A/hu unknown
- 1993-10-22 NZ NZ257117A patent/NZ257117A/en unknown
- 1993-10-22 IL IL107371A patent/IL107371A/en not_active IP Right Cessation
- 1993-10-22 AT AT93923529T patent/ATE179701T1/de not_active IP Right Cessation
- 1993-10-22 PL PL93304676A patent/PL174416B1/pl unknown
- 1993-10-22 RU RU94036775A patent/RU2126403C1/ru active
- 1993-10-22 WO PCT/EP1993/002924 patent/WO1994011347A1/en active IP Right Grant
- 1993-10-22 ES ES93923529T patent/ES2133415T3/es not_active Expired - Lifetime
- 1993-10-22 CA CA002127536A patent/CA2127536C/en not_active Expired - Fee Related
- 1993-10-28 TW TW082108991A patent/TW233297B/zh active
- 1993-11-02 US US08/144,514 patent/US5424328A/en not_active Expired - Lifetime
- 1993-11-03 ZA ZA938206A patent/ZA938206B/xx unknown
- 1993-11-17 CN CN93114768A patent/CN1093702A/zh active Pending
-
1994
- 1994-07-15 FI FI943376A patent/FI943376A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5424328A (en) | 1995-06-13 |
ATE179701T1 (de) | 1999-05-15 |
IL107371A (en) | 1998-02-08 |
PL304676A1 (en) | 1995-01-09 |
NZ257117A (en) | 1995-08-28 |
DE69324794T2 (de) | 1999-12-02 |
CA2127536A1 (en) | 1994-05-26 |
JP3794696B2 (ja) | 2006-07-05 |
EP0623114B1 (en) | 1999-05-06 |
FI943376A (fi) | 1994-07-15 |
GB9224144D0 (en) | 1993-01-06 |
DE69324794D1 (de) | 1999-06-10 |
HUT70395A (en) | 1995-10-30 |
FI943376A0 (fi) | 1994-07-15 |
TW233297B (ja) | 1994-11-01 |
ES2133415T3 (es) | 1999-09-16 |
HU9401948D0 (en) | 1994-09-28 |
CN1093702A (zh) | 1994-10-19 |
RU94036775A (ru) | 1996-05-27 |
CA2127536C (en) | 2005-09-06 |
EP0623114A1 (en) | 1994-11-09 |
IL107371A0 (en) | 1994-01-25 |
RU2126403C1 (ru) | 1999-02-20 |
PL174416B1 (pl) | 1998-07-31 |
AU5336494A (en) | 1994-06-08 |
ZA938206B (en) | 1994-06-10 |
WO1994011347A1 (en) | 1994-05-26 |
AU666793B2 (en) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE62106B1 (en) | "Substituted imidazolyl-alkyl-piperazine and-diazepine derivatives" | |
JP3026845B2 (ja) | ピペリジン誘導体 | |
JP3315144B2 (ja) | 置換イミダゾール−2−オンの誘導体及びその製造方法 | |
EP0711296B1 (en) | IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL[5,1-c][1,4]BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS | |
JP3615550B2 (ja) | イミダゾ[1,5−a]インドール−3−オンのアザビシクロアルキル誘導体およびそれらの製造法 | |
JPH07503256A (ja) | フェニルイミダゾリジノン誘導体およびその製造法 | |
JP6884973B2 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
JPH0372061B2 (ja) | ||
EP0525879A1 (en) | Pyrazole derivatives | |
JP3657986B2 (ja) | イミダゾ〔1,5−a〕インドール−3−オンのイミダゾリルアルキル誘導体およびそれらの製造法 | |
JPH0386876A (ja) | ベンゾイソキノリン誘導体 | |
JPH03506032A (ja) | 中枢神経系活性を有するアセチレン系イミダゾール | |
HU184705B (en) | Process for preparing 9-/3-/3,5-cys-dimethyl-piperazino/-propyl/-carbazole further salts or solvates of salts of this compound | |
JP3786985B2 (ja) | ピロリジノン誘導体 | |
JPH05271230A (ja) | ジアザビシクロ誘導体 | |
JPH03258781A (ja) | チオピラノ〔2,3―b〕インドール誘導体及びこれを含有する医薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050222 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050516 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050627 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050822 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051004 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060328 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060411 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |